n,n-dimethylarginine has been researched along with Diabetic Retinopathy in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Guo, X; Jin, W; Xing, Y | 1 |
Huang, CY; Jiang, JL; Li, G; Li, MY; Wu, MT; Xiong, XM; Zhou, T | 1 |
Balasubramanyam, M; Jayachandran, I; Manickam, N; Mohan, V; Paadukaana, S; Sundararajan, S; Venkatesan, S | 1 |
Du, MR; Jiang, JL; Li, NS; Wang, YJ; Yan, L; Zhou, T | 1 |
Chen, W; He, K; Li, C; Liu, J; Ma, B; Ma, H; Tian, L; Zhao, P | 1 |
Hernández, C; Simó, R; Simó-Servat, O | 1 |
Chen, Y; Gu, Q; Sheng, M; Xu, X; Zhang, X; Zheng, Z | 1 |
3 review(s) available for n,n-dimethylarginine and Diabetic Retinopathy
Article | Year |
---|---|
Role of ADMA in the pathogenesis of microvascular complications in type 2 diabetes mellitus.
Topics: Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Retinopathy; Humans | 2023 |
Relationship between Serum Asymmetric Dimethylarginine Level and Microvascular Complications in Diabetes Mellitus: A Meta-Analysis.
Topics: Arginine; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Female; Humans; Male; Risk Factors | 2019 |
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on Physiopathology.
Topics: Adrenomedullin; Arginine; Autoantibodies; Basement Membrane; Biomarkers; C-Reactive Protein; Collagen Type IV; Diabetic Retinopathy; E-Selectin; Endothelial Progenitor Cells; Extracellular Matrix; Glycation End Products, Advanced; Homocysteine; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Laminin; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MicroRNAs; Retinol-Binding Proteins, Plasma; RNA, Messenger; Tissue Inhibitor of Metalloproteinase-1; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1 | 2016 |
4 other study(ies) available for n,n-dimethylarginine and Diabetic Retinopathy
Article | Year |
---|---|
Asymmetric dimethylarginine aggravates blood-retinal barrier breakdown of diabetic retinopathy via inhibition of intercellular communication in retinal pericytes.
Topics: Animals; Apoptosis; Arginine; Blood-Retinal Barrier; Cell Communication; Cell Membrane Permeability; Cells, Cultured; Connexin 43; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Gap Junctions; Glucose; Male; Pericytes; Rats; Rats, Sprague-Dawley; Streptozocin | 2019 |
Asymmetric dimethylarginine (ADMA) accelerates renal cell fibrosis under high glucose condition through NOX4/ROS/ERK signaling pathway.
Topics: Animals; Arginine; Cell Line; Cell Movement; Cell Proliferation; Cells, Cultured; Diabetic Retinopathy; Fibroblasts; Fibrosis; Glucose; Kidney; MAP Kinase Signaling System; Mesangial Cells; Models, Biological; NADPH Oxidase 4; Rats; Reactive Oxygen Species | 2020 |
Asymmetric dimethylarginine contributes to retinal neovascularization of diabetic retinopathy through EphrinB2 pathway.
Topics: Amidohydrolases; Animals; Arginine; Cell Hypoxia; Cell Line; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Ephrin-B2; Human Umbilical Vein Endothelial Cells; Humans; Macaca mulatta; Male; Protein-Arginine N-Methyltransferases; Rats, Sprague-Dawley; Retinal Neovascularization; Retinal Vessels; RNA Interference; Signal Transduction | 2018 |
PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
Topics: Amidohydrolases; Animals; Arginine; Blotting, Western; Cells, Cultured; Cyclic GMP; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Endothelial Cells; Male; Protein-Arginine N-Methyltransferases; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Renin-Angiotensin System; Up-Regulation | 2009 |